BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Genetown

  Intact Medical Corporation’s Intact (TM) Breast Lesion Excision System Qualifies For Higher Reimbursement Rate

  June 7, 2006

   · 

  1 min read
• Business

  Novogen Limited Renegotiates Phenoxodiol License Payment

  June 7, 2006

   · 

  1 min read
• Drug Development

  Cytogen Corporation Release: Data Presented At SNM Meeting Demonstrate Novel Therapeutic Combinations And Applications For QUADRAMET(R)

  June 7, 2006

   · 

  1 min read
• Drug Development

  Incyte Corporation Begins Phase I Study Of INCB13739 As A New Treatment For Type 2 Diabetes

  June 7, 2006

   · 

  1 min read
• Vasogen To Present At Needham & Company Biotechnology And Medical Technology Conference

  June 7, 2006

   · 

  1 min read
• Genetown

  Charles River Laboratories (Massachusetts) Prices $300 Million Convertible Senior Notes

  June 7, 2006

   · 

  1 min read
• Biotech Beach

  Invitrogen Corporation To Host Live Webcast Of 2006 Investor Meeting

  June 7, 2006

   · 

  1 min read
• BioCapital

  Incyte Corporation To Present At Needham Conference

  June 7, 2006

   · 

  1 min read
• Biotech Beach

  Stratagene To Present At The Pacific Growth Equities Life Sciences Growth Conference

  June 7, 2006

   · 

  1 min read
• Genetown

  Cubist Pharmaceuticals, Inc. Completes Offering Of $350 Million In 2.25% Convertible Subordinated Notes Due 2013

  June 7, 2006

   · 

  1 min read